Amphotericin B liposomal 50mg powder for dispersion for infusion vials
NHS hospitals in England used £23,847,358 of indicative cost of Amphotericin B liposomal 50mg powder for dispersion for infusion vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 0.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Amphotericin B liposomal 50mg powder for dispersion for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Amphotericin B liposomal 50mg powder for dispersion for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| King's College Hpl Nhs Foundation Trust | £1,279,156 |
| Manchester University Nhs Ft | £1,050,440 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,048,410 |
| Nottingham University Hospitals Trust | £1,028,105 |
| Barts Health Nhs Trust | £985,271 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £926,375 |
| Imperial College Healthcare Nhs Trust | £863,152 |
| University College London Foundation Tr | £849,518 |
| Cambridge Univ Hosp Nhs Foundation Trust | £778,064 |
| University Hospital Southampton Nhs Ft | £736,294 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.